- Dramatic Decline of PSA and Symptom Improvement after Estramustine Withdrawal in a Hormone-refractory Prostate Cancer Patient
-
Mo KI, Kim KH, Seo YJ, Lee KS
- KMID: 1990230
- Korean J Urol.
- 2007 Jul;48(7):751-753.
- doi: 10.4111/kju.2007.48.7.751
In some patients with prostate cancer and who manifest disease progression during maximal androgen blockade(MAB) therapy, discontinuation of antiandrogen treatment might result in a significant fall in the level of... -
- CITED
-
- Close
- SHARE
-
- Close
- Estramustine Phosphate Based Chemotherapy for Hormone Refractory Prostate Cancer
-
Han KS, Cho KS, Lee SH, Hong SJ
- KMID: 1990218
- Korean J Urol.
- 2007 Jul;48(7):684-690.
- doi: 10.4111/kju.2007.48.7.684
PURPOSE: We wanted to evaluate the efficacy and side effects of estramustine monotherapy and estramustine plus etoposide or dexamethasone combined therapies for patients with hormone refractory prostate cancer(HRPC). MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Ketoconazole and Estramustine for Treating Patients with Castration-Resistant Prostate Cancer
-
Yun BH, Hwang EC, Yoo DH, Hwang IS, Kim SO, Jung SI, Kang TW, Kwon DD, Park K, Ryu SB
- KMID: 2315399
- Korean J Urol.
- 2011 Nov;52(11):746-751.
PURPOSE: We investigated the efficacy of ketoconazole and estramustine before chemotherapy for treating patients with progressive castration-resistant prostate cancer (CRPC) after anti-androgen withdrawal syndrome. MATERIALS AND METHODS: Eighty-four patients who were... -
- CITED
-
- Close
- SHARE
-
- Close
